Invalda INVL investor's calendar for 2026

Invalda INVL plans to publish information to investors in 2026 in accordance with the following calendar:
8 April 2026 – audited annual financial statements and annual management report.
29 May 2026 – factsheet for 3 months of 2026.
31 August 2026 – semi–annual report of 2026.
30 November 2026 – factsheet for 9 months of 2026.

The person for additional information:
Raimondas Rajeckas
CFO of Invalda INVL
[email protected]

You May Also Be Interested In

• Breaking into the Global Top Three for Premium Displays, Chinese Smartphone Brand iQOO Set to Unveil a Breakthrough Display Product
• ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTI
• Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer